| CSF1R‐and SHP2‐inhibitor‐loaded nanoparticles enhance cytotoxic activity and phagocytosis in tumor‐associated macrophages A Ramesh, S Kumar, D Nandi, A Kulkarni Advanced Materials 31 (51), 1904364, 2019 | 172 | 2019 |
| Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy A Ramesh, A Brouillard, S Kumar, D Nandi, A Kulkarni Biomaterials 227, 119559, 2020 | 76 | 2020 |
| A Nitric Oxide (NO) Nanoreporter for Noninvasive Real‐Time Imaging of Macrophage Immunotherapy A Ramesh, S Kumar, A Brouillard, D Nandi, A Kulkarni Advanced Materials 32 (24), 2000648, 2020 | 73 | 2020 |
| Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy A Nguyen, A Ramesh, S Kumar, D Nandi, A Brouillard, A Wells, ... Science advances 6 (40), eabc2777, 2020 | 56 | 2020 |
| Targeting macrophages: a novel avenue for cancer drug discovery S Kumar, A Ramesh, A Kulkarni Expert Opinion on Drug Discovery 15 (5), 561-574, 2020 | 35 | 2020 |
| Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy A Ramesh, S Kumar, A Nguyen, A Brouillard, A Kulkarni Nanoscale 12 (3), 1875-1885, 2020 | 29 | 2020 |
| Inhaled drug delivery for the targeted treatment of asthma A Boboltz, S Kumar, GA Duncan Advanced Drug Delivery Reviews 198, 114858, 2023 | 9 | 2023 |
| Nanotheranostic strategies for cancer immunotherapy A Nguyen, S Kumar, AA Kulkarni Small methods 6 (12), 2200718, 2022 | 9 | 2022 |
| Immunotherapy: CSF1R‐and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages (Adv. Mater. 51/2019) A Ramesh, S Kumar, D Nandi, A Kulkarni Advanced Materials 31 (51), 1970362, 2019 | | 2019 |
Ashish KulkarniAssociate Professor, University of Massachusetts-Amherst在 engin.umass.edu 的电子邮件经过验证
